Assessment of Hypertensive Patients’ Complex Metabolic Status Using Data Mining Methods

Author:

Kovács Beáta1,Németh Ákos1,Daróczy Bálint23ORCID,Karányi Zsolt1,Maroda László4,Diószegi Ágnes1,Harangi Mariann15ORCID,Páll Dénes4

Affiliation:

1. Division of Metabolic Diseases, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary

2. Institute for Computer Science and Control (SZTAKI), Hungarian Research Network, H-1111 Budapest, Hungary

3. Department of Mathematical Engineering (INMA/ICTEAM), Université Catholique de Louvain, 1348 Louvain-la-Neuve, Belgium

4. Department of Medical Clinical Pharmacology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary

5. Institute of Health Studies, Faculty of Health Sciences, University of Debrecen, H-4032 Debrecen, Hungary

Abstract

Cardiovascular diseases are among the leading causes of mortality worldwide. Hypertension is a preventable risk factor leading to major cardiovascular events. We have not found a comprehensive study investigating Central and Eastern European hypertensive patients’ complex metabolic status. Therefore, our goal was to calculate the prevalence of hypertension and associated metabolic abnormalities using data-mining methods in our region. We assessed the data of adults who visited the University of Debrecen Clinical Center’s hospital (n = 937,249). The study encompassed data from a period of 20 years (2001–2021). We detected 292,561 hypertensive patients. The calculated prevalence of hypertension was altogether 32.2%. Markedly higher body mass index values were found in hypertensive patients as compared to non-hypertensives. Significantly higher triglyceride and lower HDL-C levels were found in adults from 18 to 80 years old. Furthermore, significantly higher serum glucose and uric acid levels were measured in hypertensive subjects. Our study confirms that the calculated prevalence of hypertension is akin to international findings and highlights the extensive association of metabolic alterations. These findings emphasize the role of early recognition and immediate treatment of cardiometabolic abnormalities to improve the quality of life and life expectancy of hypertensive patients.

Funder

National Research, Development and Innovation Office—NKFIH

MTA Premium Postdoctoral Grant 2018

Ministry of Innovation and Technology NRDI Office

Publisher

MDPI AG

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics

Reference32 articles.

1. Mortality patterns in hypertension;Arima;J. Hypertens.,2011

2. Global burden of blood-pressure-related disease, 2001;Lawes;Lancet,2008

3. NCD Risk Factor Collaboration (NCD-RisC) (2017). Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet, 389, 37–55.

4. Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies from 90 Countries;Mills;Circulation,2016

5. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries;Chow;JAMA,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3